Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 614-144-2 | CAS number: 67800-94-6
Endpoint summary
Administrative data
Description of key information
28-day oral (gavage) NOAEL for both sexes was concluded as 40 mg/kg b.w./d ( based on nominal) based on histopathological changes in the liver and thyroids (read across from oTDA, propoxylated).
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 40 mg/kg bw/day
Additional information
Results 'read across' from study on oTDA, propxylated, as permitted by Annex XI para 1.5, based on the justification in the report by Paul Illing Consultancy Services Ltd. and Marlin Consultancy (Illing and Barratt, 2010). Thus, on animal welfare grounds this test should not be undertaken on oTDA, ethoxylated and propoxylated. For further details concerning the grouping, consult Illing and Barratt, 2010.
The NOAEL for both sexes was concluded as 40 mg/kg b.w. /d (based on nominal).
Repeated dose toxicity: inhalation - systemic effects (target organ) digestive: liver; glandular: thyroids
Justification for classification or non-classification
According to Regulation (EC) No 1272/2008, Annex I, chapter 3.9 classification of Diaminotoluene, propoxylated as STOT RE cat. 2 is not recommended.Although the LOAEL (160 mg/kg) is below the guidance value for 28-day studies (300 mg/kg), the nature and severity of the adverse effects at this dose level do not support classification. Hematological changes at 160 mg/kg (females) and even at 640 mg/kg (females/males) give no conclusive evidence of consistent and significant adverse effect in hematology. The periportal hepatocellular changes observed at 160 mg/kg (2/5 males and 5/5 females grade 2) and even at 640 mg/kg (5/5 male and 5/5 female, grade 3) give no evidence of multifocal or diffuse necrosis, fibrosis or granuloma formation. The morphological alterations comply with those typical for reversible hepatic changes due to liver enzymes induction reflecting increased metabolism and hepatic clearance of Diaminotoluene, propoxylated. The follicular cell hyperthrophy/hyperplasie in the thyroids, observed in both genders up to a moderate degree at 160 mg/kg (grade 2) and 640 mg/kg (grade 3), are interpreted as being a specific thyroid toxicity via liver enzyme induction.The species-specific mechanism/effect of toxicity observed in this study cannot be directly extrapolated to humans, i.e. these effects are therefore considered of insufficient concern for classification.
On the basis of 'read across' from oTDA, propoxylated, the findings in the available study do not warrant classification ofDiaminotoluene, ethoxylated and propoxylated according to the EU criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
